Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
The European Union’s drugs regulator is just a few weeks away from deciding whether to approve Sanofi SA (NASDAQ:SNY) and GSK…
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back…
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002,…
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
Health Canada has approved Moderna Inc's (NASDAQ:
Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster In European Union
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine
The Omicron BA.1-adapted bivalent COVID-19 vaccine combines
